More...Snapshot
Interferon a (human leukocyte protein moiety reduced). A type I interferon consisting of 165 amino acid residues with lysine in position 23. This protein is produced by recombinant DNA technology and resembles interferon secreted by leukocytes. It is used extensively as an antiviral or antineoplastic agent. An oral form is being developed by Amarillo Biosciences.
The global Interferon Alp
Table of Content
1 Industry Overview
1.1 Interferon Alpha-2a Biosimilar Industry
Figure Interferon Alpha-2a Biosimilar Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Interferon Alpha-2a Biosimilar
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Interferon Alpha-2a Biosimilar
1.2.2 Downstream